Misplaced Pages

Talk:Homeopathy: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 14:43, 18 June 2014 editKhabboos (talk | contribs)1,384 edits For your enjoyment← Previous edit Revision as of 14:59, 18 June 2014 edit undoKhabboos (talk | contribs)1,384 edits Positive studies and clinical trials: new sectionNext edit →
Line 168: Line 168:


::I got a request to sign a petition from change.org to avoid the Homeopathic section's closure at the Bristol (or was it Glasgow?) Hospital which claimed that a petition for it's closure was signed by 2000 sceptics/critics of Homeopathy, while they have 24,000 signatures to avoid its closure and were looking to make it 25,000 signatures. However, are we at wikipedia going to put such trivia into this article? I hope not!—] (]) 14:43, 18 June 2014 (UTC) ::I got a request to sign a petition from change.org to avoid the Homeopathic section's closure at the Bristol (or was it Glasgow?) Hospital which claimed that a petition for it's closure was signed by 2000 sceptics/critics of Homeopathy, while they have 24,000 signatures to avoid its closure and were looking to make it 25,000 signatures. However, are we at wikipedia going to put such trivia into this article? I hope not!—] (]) 14:43, 18 June 2014 (UTC)

== Positive studies and clinical trials ==

<b>
<p align="left">STUDIES OF THE ACTIVITY OF HOMEOPATHIC MEDICINES</p>
<div align="left">
<table height="172" width="678" border="1">
<tbody>
<tr>
<td width="171" height="9"><font size="1">ORIGINAL/TRANSLATED TITLE</font></td>
<td width="128" height="9">AUTHOR(S)</td>
<td width="84" height="9">PUBLICATION</td>
<td width="92" height="9">ACTIVITY</td>
<td width="203" height="9">STUDY</td>
</tr>
<tr>
<td width="171" height="9"><font face="Optima-Bold" size="1"><b>
<p align="left">Inhibition of lymphoblast</b></font></b> <font face="Optima-Bold" size="1"><b>transformation
test (LTT) in</b></font> <font face="Optima-Bold" size="1"><b>phytohaemagglutinin
(PHA) with</b></font> <font face="Optima-Bold" size="1"><b>Phytolacca
americana in</b></font> <b><font face="Optima-Bold" size="1">homeopathic
dilution</font></b></p>
</td>
<td width="128" height="9"><font face="Optima" size="1">
<p align="left">Colas H.,</p>
<p align="left">Aubin M.,</p>
<p align="left">Picard P.,</p>
<p align="left">Lebecq J.C.</font></p>
</td>
<td width="84" height="9"><i><font face="Optima-Oblique" size="1">
<p align="left">Ann. Hom&eacute;opat.</p>
<p align="left">Fr.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1975</font></b><font face="Optima" size="1">,
6: 1-11.</font></p>
</td>
<td width="92" height="9"><b>
<p align="left"><font face="Optima-Bold" size="1">Inhibitory</font></b></p>
</td>
<td width="203" height="9">
<p align="left"><font face="Optima" size="1">Lymphoblast</p>
<p align="left">transformation</font></p>
</td>
</tr>
<tr>
<td width="171" height="9"><font face="Optima-Bold" size="1"><b>
<p align="left">Inquiry into the limits of biological</b></font> <font face="Optima-Bold" size="1"><b>effects
of chemical compounds in</b></font> <font face="Optima-Bold" size="1"><b>tissue
culture. I. Low dose effects of</b></font> <b><font face="Optima-Bold" size="1">mercure
chloride</font></b></p>
</td>
<td width="128" height="9"><font face="Optima" size="1">
<p align="left">Mansvelt J.D.,</p>
<p align="left">van Amons E.</font></p>
</td>
<td width="84" height="9">
<p align="left"><i><font face="Optima-Oblique" size="1">Z.
Naturtorschung</font></i><font face="Optima" size="1">,</p>
</font><b><font face="Optima-Bold" size="1">
<p align="left">1975</font></b><font face="Optima" size="1">, 30:</p>
<p align="left">643-649.</font></p>
</td>
<td width="92" height="9"><b>
<p align="left"><font face="Optima-Bold" size="1">Inhibitory</font></b></p>
</td>
<td width="203" height="9"><font face="Optima" size="1">
<p align="left">Lymphocyte</p>
<p align="left">growth</font></p>
</td>
</tr>
<tr>
<td width="171" height="9"><b><font face="Optima-Bold" size="1">
<p align="left">The effects of Belladonna and</font></b> <font face="Optima-Bold" size="1"><b>Ferrum
phosphoricum on the</b></font> <font face="Optima-Bold" size="1"><b>chemoluminescence
of human</b></font> <b><font face="Optima-Bold" size="1">poly-morphonuclear
neutrophils</font></b></p>
</td>
<td width="128" height="9"><font face="Optima" size="1">
<p align="left">Poitevin B.,</p>
<p align="left">Aubin M.,</p>
<p align="left">Royer J.F.</font></p>
</td>
<td width="84" height="9"><i><font face="Optima-Oblique" size="1">
<p align="left">Ann. Hom&eacute;op. Fr.</font></i><font face="Optima" size="1">,</p>
</font><b><font face="Optima-Bold" size="1">
<p align="left">1983</font></b><font face="Optima" size="1">, 3: 5-12.</font></p>
</td>
<td width="92" height="9"><b>
<p align="left"><font face="Optima-Bold" size="1">Inhibitory</font></b></p>
</td>
<td width="203" height="9"><font face="Optima" size="1">Radical release</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Effect of aconitum and veratrum</p>
<p align="left">on the isolated perfused heart of</p>
<p align="left">the common eel </font></b><font face="Optima" size="1">(Anguilla
anguilla)</font></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Pennec J.P.,</p>
<p align="left">Aubin M.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Comp. Biochem.</p>
<p align="left">Physiol.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1984</font></b><font face="Optima" size="1">,</p>
<p align="left">776: 367-369.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">Aconitine toxicity</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Elements of homeopathic</p>
<p align="left">pharmacology</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Aubin M.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Hom&eacute;opathie</p>
<p align="left">Fran&ccedil;.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1984</font></b><font face="Optima" size="1">,
72:</p>
<p align="left">231- 235</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">Aconitine toxicity</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">The effect of homeopathic</p>
<p align="left">preparations on the phagocyte</p>
<p align="left">activity of granulocytes. In vitro</p>
<p align="left">tests and double-blind controlled</p>
<p align="left">trials</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Wagner H.,</p>
<p align="left">Jurcic K.,</p>
<p align="left">Doenicke A.,</p>
<p align="left">Rosenhuber E.,</p>
<p align="left">Behrens N.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Arzneim.</p>
<p align="left">Forsch./Drug Res.</font></i><font face="Optima" size="1">,</p>
</font><b><font face="Optima-Bold" size="1">
<p align="left">1986</font></b><font face="Optima" size="1">, 36:</p>
<p align="left">1424-1425.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">Phagocytosis</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Approach to quantitative analysis</p>
<p align="left">of the effect of Apis mellifica on</p>
<p align="left">the degranulation of human</p>
<p align="left">basophils cultivated in vitro</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Poitevin B.,</p>
<p align="left">Aubin M.,</p>
<p align="left">Benveniste J.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Innov. Tech. Biol.</p>
<p align="left">Med.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1986</font></b><font face="Optima" size="1">,
7:</p>
<p align="left">64-68.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Basophil</p>
<p align="left">degranulation</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">In vitro stimulation of human</font></b> <b><font face="Optima-Bold" size="1">granulocytes
and lymphocytes by</font></b> <font face="Optima-Bold" size="1"><b>pico-
and femtogram quantities of</b></font> <b><font face="Optima-Bold" size="1">cytostatic
agents</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Wagner H.,</p>
<p align="left">Kreher B.,</p>
<p align="left">Jurcic K.</font></p>
</td>
<td width="84" height="8"><font face="Optima-Oblique" size="1"><i>
<p align="left">Arzneim.</i></font> <b><font face="Optima-Oblique" size="1"><i>Forsch./Drug
Res.</i></font><font face="Optima" size="1">,</font></b> <b><font face="Optima-Bold" size="1">1988</font><font face="Optima" size="1">,
38:</font></b> <b><font face="Optima" size="1">273-275.</font></b></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Lymphocyte</p>
<p align="left">growth</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><font face="Optima" size="1">
<p align="left"></font><b><font face="Optima-Bold" size="1">In vitro
immunological</p>
<p align="left">degranulation of human basophils</p>
<p align="left">is modulated by lung histamine</p>
<p align="left">and Apis mellifica</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Poitevin B.,</p>
<p align="left">Davenas E.,</p>
<p align="left">Benveniste J.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Brit. J. Clin.</p>
<p align="left">Pharmacol.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1988</font></b><font face="Optima" size="1">,</p>
<p align="left">25: 439-444.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Basophil</p>
<p align="left">degranulation</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Cytotoxic agents as</p>
<p align="left">immunomodulators</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Wagner H.,</p>
<p align="left">Kreher B.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Proc. of the 3rd</p>
<p align="left">GIRI meeting</font></i><font face="Optima" size="1">,</p>
<p align="left">Paris, </font><b><font face="Optima-Bold" size="1">1989</font></b><font face="Optima" size="1">,
31-</p>
<p align="left">46.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Lymphocyte</p>
<p align="left">growth</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Contributions of fundamental</p>
<p align="left">research in homeopathy</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Boiron J.,</p>
<p align="left">Belon P.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Berl. J. Res. Hom.</font></i><font face="Optima" size="1">,</p>
</font><b><font face="Optima-Bold" size="1">
<p align="left">1990</font></b><font face="Optima" size="1">, 1: 34-35.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Basophil</p>
<p align="left">degranulation</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Synergism of action between</p>
<p align="left">indoleacetic acid (IAA) and highly</p>
<p align="left">diluted solutions of CaCO3 on the</p>
<p align="left">growth of oat coleoptiles</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">Bornoroni C.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Berl. J. Res. Hom.</font></i><font face="Optima" size="1">,</p>
</font><b><font face="Optima-Bold" size="1">
<p align="left">1991</font></b><font face="Optima" size="1">, 1 (4/5):</p>
<p align="left">275-278.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Growth of plant</p>
<p align="left">cells</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Study of the action of</p>
<p align="left">Hahnemannian dilutions of</p>
<p align="left">mercury chloride on the mitotic</p>
<p align="left">index in animal cell cultures.</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Boiron J.,</p>
<p align="left">Abecassis J.,</p>
<p align="left">Cotte J.,</p>
<p align="left">Bernard A.M.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Ann. Hom&eacute;op.</p>
<p align="left">Fr</font></i><font face="Optima" size="1">., </font><b><font face="Optima-Bold" size="1">1991</font></b><font face="Optima" size="1">,
23:</p>
<p align="left">43-49.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">Hg toxicity</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Dual effects of formylpeptides on</p>
<p align="left">the adhesion of endotoxin-primed</p>
<p align="left">human neutrophils</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Bellavite P.,</p>
<p align="left">Chirumbolo S.,</p>
<p align="left">Lippi G.,</p>
<p align="left">Andrioli G.,</p>
<p align="left">Bonazzi L.,</p>
<p align="left">Ferro I.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Cell. Biochem.</p>
<p align="left">Funct.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1993</font></b><font face="Optima" size="1">,
11:</p>
<p align="left">231-239.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Cell adhesion</p>
<p align="left">(bact. pept.</p>
<p align="left">10-8-10-9)</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Effects of homeopathic</p>
<p align="left">preparations of organic acids and</p>
<p align="left">of minerals on the oxidative</p>
<p align="left">metabolism of human neutrophils</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Chirumbolo S.,</p>
<p align="left">Signorini A.,</p>
<p align="left">Bianchi I.,</p>
<p align="left">Lippi G.,</p>
<p align="left">Bellavite P.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Br. Hom. J.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1993</font></b><font face="Optima" size="1">,</p>
<p align="left">82: 227-244.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Leucocyte</p>
<p align="left">activation</p>
<p align="left">(metabolism)</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Platelets/endothelial cells</p>
<p align="left">interactions in presence of</p>
<p align="left">acetylsalicylic acid at ultra low</p>
<p align="left">dose</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Doutremepuich</p>
<p align="left">C.,</p>
<p align="left">Lalanne M.C.,</p>
<p align="left">Ramboer I.,</p>
<p align="left">Sertillanges</p>
<p align="left">M.N.,</p>
<p align="left">De Seze O.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Omeomed 92 (C.</p>
<p align="left">Bornoroni, ed.)</font></i><font face="Optima" size="1">,</p>
</font><b><font face="Optima-Bold" size="1">
<p align="left">1993</font></b><font face="Optima" size="1">, Editrice</p>
<p align="left">Compositori,</p>
<p align="left">Bologna:</p>
<p align="left">109-115.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Prostacyclin</p>
<p align="left">release</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Effect of high dilutions of epidermal</p>
<p align="left">growth factor (EGF) on </font><i><font face="Optima-BoldOblique" size="1">in
vitro</p>
</font></i><font face="Optima-Bold" size="1">
<p align="left">proliferation of keratinocyte and</p>
<p align="left">fibroblast cell lines</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Fougeray S.,</p>
<p align="left">Moubry K.,</p>
<p align="left">Vallot N.,</p>
<p align="left">Bastide M.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Br. Hom. J.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1993</font></b><font face="Optima" size="1">,</p>
<p align="left">82: 124-125.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Growth of</p>
<p align="left">keratinocytes</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Effects of different homeopathic</p>
<p align="left">potencies of Lachesis on</p>
<p align="left">lymphocyte cultures obtained</p>
<p align="left">from rabbit blood</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Enbergs H.,</p>
<p align="left">Arndt G.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Biol. Tier., </font><b><font face="Optima-BoldOblique" size="1">1993</font></b><font face="Optima-Oblique" size="1">,</p>
<p align="left">4.</font></i></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Mitotic and</p>
<p align="left">immunostimulating</p>
<p align="left">activity (bact. pept</p>
<p align="left">10-5-10-6)</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">The effect of homeopathic</p>
<p align="left">potencies of housedust mite on</p>
<p align="left">the migration of house-dust sensitive</p>
<p align="left">human leukocytes</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Gibson S.L.,</p>
<p align="left">Gibson R.G.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Complement.</p>
<p align="left">Ther. Med.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1996</font></b><font face="Optima" size="1">,</p>
<p align="left">4: 169-171.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Leucocyte</p>
<p align="left">chemotaxis</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">The effects of Nux vomica</p>
<p align="left">Homaccord and Atropinum comp.</p>
<p align="left">on intestinal activity in vitro</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Kanui T.I.,</p>
<p align="left">Enbergs H.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Biol. Tier.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1996</font></b><font face="Optima" size="1">/1,</p>
<p align="left">43-47.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Contraction of</p>
<p align="left">intestinal muscles</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Application of flow cytometry to</p>
<p align="left">the analysis of the</p>
<p align="left">immunosuppressive effect of</p>
<p align="left">histamine dilutions on human</p>
<p align="left">basophil action: effect of</p>
<p align="left">cimetidine</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Sainte-Laudy J.,</p>
<p align="left">Belon P.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Inflamm. Res</font></i><font face="Optima" size="1">.,</p>
</font><b><font face="Optima-Bold" size="1">
<p align="left">1997</font></b><font face="Optima" size="1">, 46:</p>
<p align="left">S27-S28.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Basophil</p>
<p align="left">degranulation</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Effects of Podophillum pellatum</p>
<p align="left">compounds in various</p>
<p align="left">preparations and dilutions on</p>
<p align="left">human neutrophil functions in</p>
<p align="left">vitro</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Chirumbolo S.,</p>
<p align="left">Conforti A.,</p>
<p align="left">Lussignoli S.,</p>
<p align="left">Metelmann H.</p>
<p align="left">et Al.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Br. Hom. J</font></i><font face="Optima" size="1">., </font><b><font face="Optima-Bold" size="1">1997</font></b><font face="Optima" size="1">;</p>
<p align="left">86-16.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Release of</p>
<p align="left">superoxides</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><i><font face="Optima-BoldOblique" size="1">
<p align="left">In vivo </font></i><font face="Optima-Bold" size="1">and
</font><i><font face="Optima-BoldOblique" size="1">in vitro </font></i><font face="Optima-Bold" size="1">studies
on the</p>
<p align="left">efficiency of potentized and nonpotentized</p>
<p align="left">substances</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Harisch G.,</p>
<p align="left">Dittmann J.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">BT, </font></i><b><font face="Optima-Bold" size="1">1997</font></b><font face="Optima" size="1">,
2;</p>
<p align="left">40-46.</font></p>
</td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Difference between</p>
<p align="left">potentised and</p>
<p align="left">non-potentised</p>
<p align="left">substances</font></p>
</td>
<td width="203" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">In vivo </font></i><font face="Optima" size="1">and </font><i><font face="Optima-Oblique" size="1">in</p>
<p align="left">vitro </font></i><font face="Optima" size="1">study;
basic</p>
<p align="left">research</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Experiments with the effects of</p>
<p align="left">Ubichinon-Injeel and strong</p>
<p align="left">Ubichinon-Injeel on an acellular</p>
<p align="left">system</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Harisch G.,</p>
<p align="left">Dittmann J.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1997</font></b><font face="Optima" size="1">,
3;</p>
<p align="left">99-104.</font></p>
</td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Different effects of</p>
<p align="left">associations of</p>
<p align="left">various potencies and</p>
<p align="left">individual potencies</font></p>
</td>
<td width="203" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">In vitro </font></i><font face="Optima" size="1">study;</p>
<p align="left">basic research</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Efficacy of the homeopathic drugs</p>
<p align="left">Suis and Arnica comp.-Heel&reg; on</p>
<p align="left">lymphocyte and phagocyte</p>
<p align="left">activity</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">Enbergs H.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1998</font></b><font face="Optima" size="1">,
1;</p>
<p align="left">3-11.</font></p>
</td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Effect of</p>
<p align="left">organotherapeutics</p>
<p align="left">and Arnica comp. -</p>
<p align="left">Heel&reg; on immune</p>
<p align="left">system cells</font></p>
</td>
<td width="203" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">In vitro </font></i><font face="Optima" size="1">study;</p>
<p align="left">basic research</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Influence of dilutions and</p>
<p align="left">potencies of cAMP on different</p>
<p align="left">enzymatic systems</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Harisch G.,</p>
<p align="left">Dittmann J.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1998</font></b><font face="Optima" size="1">,
2;</p>
<p align="left">55-62.</font></p>
</td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Effects of dilutions</p>
<p align="left">and potencies of</p>
<p align="left">cAMP on some</p>
<p align="left">enzymatic activities</font></p>
</td>
<td width="203" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">In vitro </font></i><font face="Optima" size="1">study;</p>
<p align="left">basic research</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Studies of the principles of</p>
<p align="left">homeopathy; the changeover</p>
<p align="left">from </font><i><font face="Optima-BoldOblique" size="1">in
vivo </font></i><font face="Optima-Bold" size="1">to </font><i><font face="Optima-BoldOblique" size="1">in
vitro</p>
</font></i><font face="Optima-Bold" size="1">
<p align="left">experimental research</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Harisch G.,</p>
<p align="left">Dittmann J.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1998</font></b><font face="Optima" size="1">,
3;</p>
<p align="left">98-103.</font></p>
</td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Potentised and</p>
<p align="left">non-potentised</p>
<p align="left">dilutions are</p>
<p align="left">equally effective,</p>
<p align="left">but have different</p>
<p align="left">actions</font></p>
</td>
<td width="203" height="8">
<p align="left"><font face="Optima-Oblique" size="1">B</font><font face="Optima" size="1">asic
research</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><font face="Optima-Bold" size="1"><b>
<p align="left">Determination of the activity of</b></font> <b><font face="Optima-Bold" size="1">acid
phosphatase with cAMP at</font></b> <b><font face="Optima-Bold" size="1">various
potencies</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Harisch G.,</p>
<p align="left">Dittmann J.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">BM, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">,
1; 4-8.</font></td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Different effects on</font> <font face="Optima" size="1">enzymatic
activity</font></p>
</td>
<td width="203" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">In vitro </font></i><font face="Optima" size="1">study;</p>
<p align="left">basic research</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Contribution to study of the</p>
<p align="left">efficacy of homeopathic potencies</p>
<p align="left">of phosphorus</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">Gomez J.C.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">BT, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">,
2;</p>
<p align="left">53-57.</font></p>
</td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Effect of different</p>
<p align="left">potencies of</p>
<p align="left">phosphorus</font></p>
</td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Tests on guinea</p>
<p align="left">pigs</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Determination of the activity of</p>
<p align="left">acid phosphatase in the presence</p>
<p align="left">of Ubichinon comp.</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Harisch G.,</p>
<p align="left">Dittmann J.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">,
4;</p>
<p align="left">188-194.</font></p>
</td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Effect of enzymatic</p>
<p align="left">activity of</p>
<p align="left">homeopathic</p>
<p align="left">medicine</font></p>
</td>
<td width="203" height="8"><font face="Optima-Oblique" size="1">B</font><font face="Optima" size="1">asic
research</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Biochemical efficacy of</p>
<p align="left">homeopathic and electronic</p>
<p align="left">preparations of D8 potassium</p>
<p align="left">cyanate</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Dittmann J.,</p>
<p align="left">Kanapin H.,</p>
<p align="left">Harisch G.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">FKM, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">,
6;</p>
<p align="left">15-18.</font></p>
</td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Homeopathic</p>
<p align="left">potentisation is</p>
<p align="left">more effective than</p>
<p align="left">electronic</p>
<p align="left">potentisation</font></p>
</td>
<td width="203" height="8"><font face="Optima-Oblique" size="1">B</font><font face="Optima" size="1">asic
research</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Osteoporosis in vitro in rat tibiaderived</p>
<p align="left">osteoblasts is promoted</p>
<p align="left">by the homeopathic preparation,</p>
<p align="left">FMS Calciumfluor</font></b></td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Palermo C.,</p>
<p align="left">Filanti C.,</p>
<p align="left">Poggi S.,</p>
<p align="left">Manduca P.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Cell Biol Int</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">,</p>
<p align="left">23(1): 31-40.</font></td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Stimulant</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Osteogenesis</p>
<p align="left">(trial with</p>
<p align="left">compound drug)</font></td>
</tr>
<tr>
<td width="171" height="32" rowspan="2"><b><font face="Optima-Bold" size="1">
<p align="left">Thin-layer chromatography (TLC)</p>
<p align="left">of homeopathic active</p>
<p align="left">constituents</font></b></td>
<td width="128" height="32" rowspan="2"><font face="Optima" size="1">Schmolz
M.</font></td>
<td width="84" height="32" rowspan="2"><i><font face="Optima-Oblique" size="1">
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">,
5;</p>
<p align="left">248-250.</font></td>
<td width="92" height="16"><font face="Optima" size="1">
<p align="left">Constituents of</font> <font face="Optima" size="1">Arnica
comp.-</font> <font face="Optima" size="1">Heel&reg; ointment:</font> <font face="Optima" size="1">electrophoresis</font>
<font face="Optima" size="1">accelerates their</font> <font face="Optima" size="1">skin
penetration.</font> </td>
<td width="203" height="32"><font face="Optima" size="1">Basic research</font></td>
</tr>
<tr>
<td width="92" height="16"><font face="Optima" size="1">Effect of</font> <font face="Optima" size="1">homeopathic</font>
<font face="Optima" size="1">constituents on</font> <font face="Optima" size="1">enzymatic
activity.</font></td>
<td width="203" height="4"><font face="Optima" size="1">Basic research</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Efficacy of a potentised</p>
<p align="left">homeopathic drug in reducing</p>
<p align="left">cytotoxic effects produced by</p>
<p align="left">arsenic trioxide in mice</font></b></td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Datta S.,</p>
<p align="left">Mallick P.,</p>
<p align="left">Bukhsh A.R.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Complement Ther</p>
<p align="left">Med</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1999
</font></b><font face="Optima" size="1">Jan;</p>
<p align="left">7 (8): 62-75 </font><b><font face="Optima-Bold" size="1">(a).</font></b></td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Arsenic trioxide</p>
<p align="left">toxicity</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Efficacy of a potentised</p>
<p align="left">homeopathic drug in reducing</p>
<p align="left">cytotoxic effects produced by</p>
<p align="left">arsenic trioxide in mice</font></b></td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Datta S.,</p>
<p align="left">Mallick P.,</p>
<p align="left">Bukhsh A.R.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Complement Ther</p>
<p align="left">Med</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1999
</font></b><font face="Optima" size="1">Sep;</p>
<p align="left">7 (3): 156-63 </font><b><font face="Optima-Bold" size="1">(b).</font></b></td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Arsenic trioxide</p>
<p align="left">toxicity</font></td>
</tr>
<tr>
<td width="171" height="8"><font face="Optima-Bold" size="1"><b>
<p align="left">Non-cytotoxic antiviral action of</b></font> <font face="Optima-Bold" size="1"><b>a
homeopathic drug</b></font></td>
<td width="128" height="8"><font face="Optima" size="1">Heine H.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">&Auml;rzteitschrift f&uuml;r</p>
<p align="left">Neturheilverfahre</font></i><font face="Optima" size="1">,</p>
</font><b><font face="Optima-Bold" size="1">
<p align="left">2000</font></b><font face="Optima" size="1">; 41: 542-7.</font></td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td>
<td width="203" height="8"><font face="Symbol" size="1">
<p align="left">&gamma; </font><font face="Optima" size="1">interferon</p>
<p align="left">synthesis</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Efficacy of a potentised</p>
<p align="left">homeopathic drug in reducing</p>
<p align="left">cytotoxic effects produced by</p>
<p align="left">arsenic trioxide in mice</font></b></td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Kundu S.N.,</p>
<p align="left">Mitra K.,</p>
<p align="left">Khuda</p>
<p align="left">Bukhsh A.R.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Complement Ther</p>
<p align="left">Med </font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">2000
</font></b><font face="Optima" size="1">Sep;</p>
<p align="left">1 (3): 157-65.</font></td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Arsenic trioxide</p>
<p align="left">toxicity</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Stimulatory effect of some plant</p>
<p align="left">extracts used in homeopathy on</p>
<p align="left">the phagocytosis induced</p>
<p align="left">chemiluminescence of</p>
<p align="left">polymorphonuclear leukocytes</font></b></td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Crocnan D.,</p>
<p align="left">Greabu M.,</p>
<p align="left">Olinescu R.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Rocz Akad Med</p>
<p align="left">Biochemist</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">2000</font></b><font face="Optima" size="1">;</p>
<p align="left">45: 246-254.</font></td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Phagocytosis</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Difference between the efficacy</p>
<p align="left">of single potencies and chords</font></b></td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Dittmann J.,</p>
<p align="left">Harisch G.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">2000</font></b><font face="Optima" size="1">,
1;</p>
<p align="left">18-23.</font></td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Potency chords are</p>
<p align="left">more effective than</p>
<p align="left">single potencies</font></td>
<td width="203" height="8"><font face="Optima" size="1">Basic research</font></td>
</tr>
<tr>
<td width="171" height="28"><b><font face="Optima-Bold" size="1">
<p align="left">Influence of some homeopathic</p>
<p align="left">drugs on the catalytic activity of</p>
<p align="left">uricase, acid phosphatase and the</p>
<p align="left">cytosol glutathion-S-transferase</font></b></td>
<td width="128" height="28"><font face="Optima" size="1">
<p align="left">Dittmann J.,</p>
<p align="left">Kanapin H.,</p>
<p align="left">Harisch G.</font></td>
<td width="84" height="28"><i><font face="Optima-Oblique" size="1">
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">2000</font></b><font face="Optima" size="1">,
3;</p>
<p align="left">125-131</font></td>
<td width="92" height="28"><font face="Optima" size="1">
<p align="left">Effect of D8</p>
<p align="left">potencies on three</p>
<p align="left">different enzymatic</p>
<p align="left">systems</font></td>
<td width="203" height="28"><font face="Optima" size="1">Basic research</font></td>
</tr>
<tr>
<td width="171" height="37"><b><font face="Optima-Bold" size="1">
<p align="left">Influence of some homeopathic</p>
<p align="left">drugs on the catalytic activity of</p>
<p align="left">cAMP-dependent protein kinases</font></b></td>
<td width="128" height="37"><font face="Optima" size="1">
<p align="left">Dittmann J.,</p>
<p align="left">Kanapin H.,</p>
<p align="left">Harisch G.</font></td>
<td width="84" height="37"><i><font face="Optima-Oblique" size="1">
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">2000</font></b><font face="Optima" size="1">,
6;</p>
<p align="left">289-296.</font></td>
<td width="92" height="37"><font face="Optima" size="1">
<p align="left">Effect of different</p>
<p align="left">potencies of 5</p>
<p align="left">substances on</p>
<p align="left">enzymatic activity</font></td>
<td width="203" height="37"><font face="Optima" size="1">Basic research</font></td>
</tr>
<tr>
<td width="171" height="38"><b><font face="Optima-Bold" size="1">
<p align="left">Neuroprotection from glutamate</p>
<p align="left">toxicity with ultra-low dose</p>
<p align="left">glutamate</font></b></td>
<td width="128" height="38">
<p align="left"><font face="Optima" size="1">Jonas W.,</p>
<p align="left">Lin Y.,</p>
<p align="left">Zortella F.</font></td>
<td width="84" height="38"><i><font face="Optima-Oblique" size="1">
<p align="left">Neuroreport</font></i><font face="Optima" size="1">,</p>
</font><b><font face="Optima-Bold" size="1">
<p align="left">2001 </font></b><font face="Optima" size="1">Feb 92; 12</p>
<p align="left">(2): 335-9.</font></td>
<td width="92" height="38"><b><font face="Optima-Bold" size="1">Protective</font></b></td>
<td width="203" height="38"><font face="Optima" size="1">Glutamate
toxicity</font></td>
</tr>
</tbody>
</table>
</div>
<font face="Optima" size="1">
<p align="left">&nbsp;</p>
<p align="left">KEY: BT = Biomedical Therapy</p>
<p align="left">BM = Biologische Medizin</p>
<p align="left">FKM = Forschung Komplement&auml;r Medizin</p>
</font>

Revision as of 14:59, 18 June 2014

Skip to table of contents
This is the talk page for discussing improvements to the Homeopathy article.
This is not a forum for general discussion of the article's subject.
Article policies
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL
Archives: Index, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65Auto-archiving period: 30 days 
The contentious topics procedure applies to this page. This page is related to pseudoscience and fringe science, which has been designated as a contentious topic.

Editors who repeatedly or seriously fail to adhere to the purpose of Misplaced Pages, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page.

Arbitration Ruling on the Treatment of Pseudoscience

In December of 2006 the Arbitration Committee ruled on guidelines for the presentation of topics as pseudoscience in Misplaced Pages:Requests for arbitration/Pseudoscience. The final decision was as follows:

  • Neutral point of view as applied to science: Misplaced Pages:Neutral point of view, a fundamental policy, requires fair representation of significant alternatives to scientific orthodoxy. Significant alternatives, in this case, refers to legitimate scientific disagreement, as opposed to pseudoscience.
  • Serious encyclopedias: Serious and respected encyclopedias and reference works are generally expected to provide overviews of scientific topics that are in line with respected scientific thought. Misplaced Pages aspires to be such a respected work.
  • Obvious pseudoscience: Theories which, while purporting to be scientific, are obviously bogus, such as Time Cube, may be so labeled and categorized as such without more justification.
  • Generally considered pseudoscience: Theories which have a following, such as astrology, but which are generally considered pseudoscience by the scientific community may properly contain that information and may be categorized as pseudoscience.
  • Questionable science: Theories which have a substantial following, such as psychoanalysis, but which some critics allege to be pseudoscience, may contain information to that effect, but generally should not be so characterized.
  • Alternative theoretical formulations: Alternative theoretical formulations which have a following within the scientific community are not pseudoscience, but part of the scientific process.
The subject of this article is controversial and content may be in dispute. When updating the article, be bold, but not reckless. Feel free to try to improve the article, but don't take it personally if your changes are reversed; instead, come here to the talk page to discuss them. Content must be written from a neutral point of view. Include citations when adding content and consider tagging or removing unsourced information.
CautionImportant notice: Some common points of argument are addressed in the FAQ below, which represents the consensus of editors here. Please remember that this page is only for discussing Misplaced Pages's encyclopedia article about Homeopathy.
? view · edit Frequently asked questions

Some common points of argument are addressed in the FAQ below, which represents the consensus of editors here. Please remember that this page is only for discussing Misplaced Pages's encyclopedia article about Homeopathy.

To view an explanation to the answer, click the link to the right of the question. Q1: Should material critical of homeopathy be in the article? (Yes.) A1: Yes. Material critical of homeopathy must be included in the article. The articles on Misplaced Pages include information from all significant points of view. This is summarized in the policy pages which can be accessed from the Neutral point of view policy. This article strives to conform to Misplaced Pages policies, which dictate that a substantial fraction of articles in fringe areas be devoted to mainstream views of those topics. Q2: Should material critical of homeopathy be in the lead? (Yes.) A2: Yes. Material critical of homeopathy belongs in the lead section. The lead must contain a summary of all the material in the article, including the critical material. This is described further in the Lead section guideline. Q3: Is the negative material in the article NPOV? (Yes.) A3: Yes. Including negative material is part of achieving a neutral article. A neutral point of view does not necessarily equate to a sympathetic point of view. Neutrality is achieved by including all points of view – both positive and negative – in rough proportion to their prominence. Q4: Does Misplaced Pages consider homeopathy a fringe theory? (Yes.) A4: Yes. Homeopathy is described as a fringe medical system in sources reliable to make the distinction. This is defined by the Fringe theories guideline, which explains: We use the term fringe theory in a very broad sense to describe ideas that depart significantly from the prevailing or mainstream view in its particular field of study.

Since the collective weight of peer-reviewed studies does not support the efficacy of homeopathy, it departs significantly enough from the mainstream view of science to be considered a fringe theory.

References

  1. Jonas, WB; Ives, JA (February 2008). "Should we explore the clinical utility of hormesis". Human & Experimental Toxicology. 27 (2): 123–127. PMID 18480136.
Q5: Should studies that show that homeopathy does not work go into the article? (Yes.) A5: Yes. Studies that show that homeopathy does not work are part of a full treatment of the topic and should go into the article. Misplaced Pages is not the place to right great wrongs. Non-experts have suggested that all the studies that show homeopathy does not work are faulty studies and are biased, but this has not been borne out by the mainstream scientific community. Q6: Should another article called "Criticism of homeopathy" be created? (No.) A6: No. Another article called "Criticism of homeopathy" should not be created. This is called a "POV fork" and is discouraged. Q7: Should alleged proof that homeopathy works be included in the article? (No.) A7: No. Alleged proof that homeopathy works should not be included in the article. That is because no such proof has come from reliable sources. If you have found a reliable source, such as an academic study, that you think should be included, you can propose it for inclusion on the article’s talk page. Note that we do not have room for all material, both positive and negative. We try to sample some of each and report them according to their prominence. Note also that it is not the job of Misplaced Pages to convince those people who do not believe homeopathy works, nor to dissuade those who believe that it does work, but to accurately describe how many believe and how many do not believe and why. Q8: Should all references to material critical of homeopathy be put in a single section in the article? (No.) A8: No. Sources critical of homeopathy should be integrated normally in the course of presenting the topic and its reception, not shunted into a single criticism section. Such segregation is generally frowned upon as poor writing style on Misplaced Pages. Q9: Should the article mention that homeopathy might work by some as-yet undiscovered mechanism? (No.) A9: No. The article should not mention that homeopathy might work by some as-yet undiscovered mechanism. Misplaced Pages is not a place for original research or speculation. Q10: Is the article with its negative material biased? (No.) A10: No. The article with its negative material is not biased. The article must include both positive and negative views according to the policies of Misplaced Pages. Q11: Should the article characterize homeopathy as a blatant fraud and quackery? (No.) A11: No. Inflammatory language does not serve the purpose of an encyclopedia; it should only be done if essential to explain a specific point of view and must be supported from a reliable source. Misplaced Pages articles must be neutral and reflect information found in reliable sources. Misplaced Pages is an encyclopedia and not a consumer guide, so while scientific sources commonly characterise homeopathy as nonsense, fraud, pseudoscience and quackery - and the article should (and does) report this consensus - ultimately the reader should be allowed to draw his/her own conclusions.
Former good articleHomeopathy was one of the Natural sciences good articles, but it has been removed from the list. There are suggestions below for improving the article to meet the good article criteria. Once these issues have been addressed, the article can be renominated. Editors may also seek a reassessment of the decision if they believe there was a mistake.
Article milestones
DateProcessResult
September 14, 2006Good article nomineeNot listed
September 27, 2007Good article nomineeListed
October 8, 2007Good article reassessmentDelisted
October 13, 2007Good article reassessmentDelisted
October 19, 2007Peer reviewReviewed
October 25, 2007Good article nomineeListed
February 9, 2008Peer reviewReviewed
March 2, 2009Peer reviewReviewed
April 4, 2009Featured article candidateNot promoted
November 2, 2012Good article reassessmentDelisted
Current status: Delisted good article
This article has not yet been rated on Misplaced Pages's content assessment scale.
It is of interest to the following WikiProjects:
Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.
WikiProject iconSkepticism High‑importance
WikiProject iconThis article is within the scope of WikiProject Skepticism, a collaborative effort to improve the coverage of science, pseudoscience, pseudohistory and skepticism related articles on Misplaced Pages. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.SkepticismWikipedia:WikiProject SkepticismTemplate:WikiProject SkepticismSkepticism
HighThis article has been rated as High-importance on the project's importance scale.
WikiProject iconHomeopathy (inactive)
WikiProject iconThis article is within the scope of WikiProject Homeopathy, a project which is currently considered to be inactive.HomeopathyWikipedia:WikiProject HomeopathyTemplate:WikiProject HomeopathyHomeopathy
Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.
WikiProject iconAlternative medicine
WikiProject iconThis article is within the scope of WikiProject Alternative medicine, a collaborative effort to improve the coverage of Alternative medicine related articles on Misplaced Pages. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Alternative medicineWikipedia:WikiProject Alternative medicineTemplate:WikiProject Alternative medicineAlternative medicine
Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.
WikiProject iconAlternative views High‑importance
WikiProject iconThis article is within the scope of WikiProject Alternative views, a collaborative effort to improve Misplaced Pages's coverage of significant alternative views in every field, from the sciences to the humanities. If you would like to participate, please visit the project page, where you can join the discussion.Alternative viewsWikipedia:WikiProject Alternative viewsTemplate:WikiProject Alternative viewsAlternative views
HighThis article has been rated as High-importance on the project's importance scale.
Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.
WikiProject iconMedicine Mid‑importance
WikiProject iconThis article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Misplaced Pages talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine
MidThis article has been rated as Mid-importance on the project's importance scale.
WikiProject iconCitizendium Porting (inactive)
WikiProject iconThis article is within the scope of WikiProject Citizendium Porting, a project which is currently considered to be inactive.Citizendium PortingWikipedia:WikiProject Citizendium PortingTemplate:WikiProject Citizendium PortingCitizendium Porting

Template:Vital article

There have been attempts to recruit editors of specific viewpoints to this article, in a manner that does not comply with Misplaced Pages's policies. Editors are encouraged to use neutral mechanisms for requesting outside input (e.g. a "request for comment", a third opinion or other noticeboard post, or neutral criteria: "pinging all editors who have edited this page in the last 48 hours"). If someone has asked you to provide your opinion here, examine the arguments, not the editors who have made them. Reminder: disputes are resolved by consensus, not by majority vote.


Archives

Index 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
11, 12, 13, 14, 15, 16, 17, 18, 19, 20
21, 22, 23, 24, 25, 26, 27, 28, 29, 30
31, 32, 33, 34, 35, 36, 37, 38, 39, 40
41, 42, 43, 44, 45, 46, 47, 48, 49, 50
51, 52, 53, 54, 55, 56, 57, 58, 59, 60
61, 62, 63, 64, 65



This page has archives. Sections older than 30 days may be automatically archived by Lowercase sigmabot III when more than 1 section is present.


Pseodoscience

The article calls homeopathy a pseudoscience, but nowhere in wikipedia's guidelines does this seem to be allowed. Misplaced Pages:Fringe_theories There is no scientific consensus that homeopathy is pseudoscience, especially in Europe, therefore, it is classified as a questionable science. Klocek (talk) 12:11, 25 May 2014 (UTC)

It's not explicitly stated, in the Misplaced Pages guidelines that anything should be called anything. The thing is that there is nothing in the guidelines that says it shouldn't be - and anything that's not forbidden is OK. What we ARE required to do is to represent the world from a mainstream scientific perspective and to provide references for what we say.
The mainstream scientific view is that Homeopathy is a pseudoscience...and we have references to prove that. So there is no reason we shouldn't say so. More importantly, the WP:FRINGE guidelines make it clear that it would be a breach of the neutral position to allow the homeopathists to dominate the content of the article with their bogus (according to mainstream science - and therefore according to Misplaced Pages) position.
Aside from all of that - you may ask why poor old homeopathy is being called a pseudoscience in the first place? Some see this word as some kind of an insult. It's not, it's a straightforward classification of an idea or discipline. The definition of the word pseudoscience given in most dictionaries agrees with the one provided by Wiktionary, which I'll quote for you:
Any body of knowledge purported to be scientific or supported by science but which fails to comply with the scientific method.
Homeopathy undoubtedly purports to be scientific - it makes MANY claims to be able to produce certain results from certain practices based on scientific-sounding descriptions of some very odd properties of water.
The deciding factor is therefore whether or not homeopathy follows "The Scientific Method".
I suggest you read at least the introduction to our Scientific method article...but here is a summary of what this means:
Basically, the scientific method requires that you form an idea which you are not yet certain about. We call that a "hypothesis". A good hypothesis has to explain everything that we already know about the topic and then makes certain testable predictions about the universe. The next step is that you do some experiments to see if those predictions turn out to be true - and if they do, your hypothesis is a better explanation for how the universe works than the one we already have. So you write a paper describing your new hypothesis, what predictions you made, what experiments you did, what results you got and how you interpret those results to back up your hypothesis. This paper is then peer-reviewed for obvious mistakes and deceptions and to be sure that nobody else already showed it was true. That's by a bunch of other people who work in that field ("your peers") - and if it passes muster, it'll be published in some journal or other. If the hypothesis is reasonably compelling, other scientists will attempt to repeat your experiments to see if what you did really works as you claim and they may try to come up with alternative explanations for what you observed. They write more papers - perhaps devise more experiments to test your claims. Eventually, if enough of the other people who test this agree that your hypothesis is the best explanation for the experimental results, your hypothesis becomes accepted into the mainstream as a "theory". (Which is what used to be called a "law").
So - the burning question here is: Do homeopathists do this? The answer is a blindingly clear "NO!" - they most certainly do not. What they did is to come up with two basic hypotheses:
  1. Diluting something until there is none left 'imprints' the water in some permanent or at least long-lived fashion.
  2. Drinking imprinted water affects your health in some manner - possibly the reverse of the harm that would be caused by ingesting the original substance.
What experiments have been done to follow up on (1)? The answer is - none whatever. Not one single documented example of a homeopathist systematically testing whether water takes on this "imprint" has ever been performed! Where are the double-blind studies of (2)? Where is the statistical analysis of how many people were cured of their colds by very diluted raw duck liver?
That is why we call homeopathy a "pseudoscience" - it makes scientific claims - but never does the hard work to test them...instead they skip the basic science, skip the human trials and go straight to selling the stuff in little bottles in WalMart.
Misplaced Pages says that homeopathy is a pseudoscience because that is precisely, and undeniably what it is. This is the mainstream view of scientists - and it clearly follows the definition of the word and what is going on in the world of homeopathy.
We don't say that religions are pseudosciences because they tell people to take their wild and crazy claims on faith - and (with some exceptions) tend not to make scientific predictions or wrap themselves in the mantle of science. We don't say that quantum physics is pseudoscience because although quantum physicists make scientific claims, they really do follow the scientific method.
SteveBaker (talk) 12:54, 25 May 2014 (UTC)

Klocek (talk · contribs) - there is a scientific consensus that homoeopathy is pseudoscience, including "in Europe". Barney the barney barney (talk) 13:14, 25 May 2014 (UTC)

There is no consensus that homeopathy is pseudoscience --24.107.242.181 (talk) 02:40, 2 June 2014 (UTC)
Yes, there is. Homeopathy with astrology are the textbook case of obvious pseudoscience.--McSly (talk) 02:43, 2 June 2014 (UTC)
no - you are wrong - look what the best review for oscillo says — Preceding unsigned comment added by 24.107.242.181 (talk) 02:50, 2 June 2014 (UTC)
While SteveBaker provides an excellent explanation above, the real reason the article includes "Homeopathy is a pseudoscience" is the which (in the article) point to reliable sources that verify the statement. Anyone wanting to contest the statement needs to explain how the sources are incorrectly used, or provide other specific evidence to contradict the statement—bearing in mind that reliable sources are required. Johnuniq (talk) 04:16, 2 June 2014 (UTC)
Assuming that by "the best review for oscillo" you mean the Cochrane review, it doesn't say anything about whether or not homoeopathy is regarded as pseudoscience, so cannot be used as a source on this point. Brunton (talk) 07:15, 2 June 2014 (UTC)
Incidentally, if we need more sourcing for this, several of the essays in the book Philosophy of Pseudoscience (ed. Massimo Pigliucci and Maarten Boudry) recently published by the University of Chicago Press use homoeopathy as an example of pseudoscience, for example (p. 30), "Despite the lack of generally accepted demarcation criteria, we find remarkable agreement among virtually all philosophers and scientists that fields like astrology, creationism, homeopathy are either pseudosciences or at least lack the epistemic warrant to be taken seriously", or (p. 49), "homeopathy is a paradigmatic example of pseudoscience". Brunton (talk) 07:41, 2 June 2014 (UTC)

correcting misrepresentative opinion

The asertion of the UK House of Commons Scientific Select Committee is contentious with regard to the support garnered from within the committe, it noted that only three of those sitting actually voted and of those three none had any specilaist knowledge of the subject. No Health Care Trust at the time were invited to speak neither was representatives from Homeopathic association and not least no patient was afforded the same opportunity. As to the closing Paragraph remark that the government agrees is disingenous especial in light of Observations on the report Evidence Check 2: Homeopathy by the House Of Commons Science and Technology Committee, February 2010,which noted,these limitations make the Committee’s report an unreliable source of evidence about homeopathy. The jury must still be regarded as out on its efficacy and risk/ benefit ratio. Whether more research should be done, and of what kind, is another question. But there can be no ethical objection to it since the principal questions have not, as the Committee claimed, “been settled already”. Earl Baldwin of Bewdley. June 2010. Added to which 206 sitting MPs signed an early day motion expressing concerns over the report content and procedure — Preceding unsigned comment added by 80.2.37.152 (talk) 22:11, 11 June 2014 (UTC)

It is a direct quote from the report. If you want to have this modified or removed you will have to provide a WP:RS source of equal or greater weight which clearly contradicts the report. What you have provide so far is primarily WP:OR . --Daffydavid (talk) 00:17, 12 June 2014 (UTC)
That EDM was by David Tredinnick (politician). 'Nuff said. LeadSongDog come howl! 17:04, 15 June 2014 (UTC)

Better Source for Placebo Claim?

The lede makes the strong claim that "its remedies have been found to be no more effective than placebos" yet the cited source is much less committal in its interpretation:

Biases are present in placebo-controlled trials of both homoeopathy and conventional medicine. When account was taken for these biases in the analysis, there was weak evidence for a specific effect of homoeopathic remedies, but strong evidence for specific effects of conventional interventions. This finding is compatible with the notion that the clinical effects of homoeopathy are placebo effects.

Surely there is a better source, that more firmly supports the statement in the lede? I'd rather not back up an assertion that "homeopathic remedies have been found to be no more effective than placebos" with a finding that "there was weak evidence for a specific effect of homeopathic remedies." Most studies I've found online are meta-studies that are themselves based on analysis of earlier studies, many of which were conducted with the intention of proving that homeopathy works. So the meta-studies generally take the approach of finding flaws with the earlier studies, or cross-referencing effects to smooth out differences and reduce the significance of measured effects. I understand why they need to do this (nobody but homeopathy supporters tend to want to fund large-scale studies of homeopathy) but for something that is so widely accepted as pseudoscience among the mainstream medical community, surely there is some primary research with a less wishy-washy demonstration of the placebo claim?

Also, the same source is actually listed twice in the references. I'd try to fix it but the proper syntax for handling citations in Misplaced Pages is.. less than obvious to me. --Pyrrhoneia (talk) 05:36, 12 June 2014 (UTC)

Extremely high dilutions as basically only line of argument against homeopathy over several paragraphs?

Over several paragraphs in the "Evidence and Efficacy" section of the article, homeopathy is dismissed with the sole argument that extremely high dilutions (over D20/C10) statistically leave none of the original substance in the final product:
"The low concentration of homeopathic remedies, which often lack even a single molecule of the diluted substance..."
"The extreme dilutions used in homeopathic preparations often leave none of the original substance in the final product."
"The extremely high dilutions in homeopathy preclude a biologically plausible mechanism of action."
This, of course is statistically true for those extreme dilutions. However, this argumentation (and, I reiterate, this argumentation is basically used as the sole argument in those paragraphs) ignores that most homeopathic medications are usally administered at far lower dilutions (D3 to D12), which do not pose the need to argue with "water memory" or "quantum effects", as even a dilution as high as D12 (X12) still contains roughly 10 substance molecules per mol (14g/0.5oz) of water. I think pointing out the impossible "high" dilutions as the sole line of argumentation while completely ignoring the "lower" dilutions is a structural flaw of those paragraphs and should be adressed. -- megA (talk) 21:58, 12 June 2014 (UTC)

There is a section discussing high dilution, under the "Plausibility" sub-heading. But it is not by any means the "only line of argument", nor even the major one. There is more emphasis on the lack of reliable evidence for homeopathy's effectiveness. After all, as my grandmother used to say "the proof of the pudding is in the eating". --Gronk Oz (talk) 00:44, 13 June 2014 (UTC)

Gronk Oz, MegA is correct. While there are various other reasons to doubt the claims of homeopathy, they are nonetheless not adequately addressed in the specified paragraphs. MegA's point was about the article, not about homeopathy. This article actually does a pretty terrible job of providing references explaining why homeopathy is considered a pseudoscience. I came here looking for an easily accessible list of such references, but most of the cited sources are meta-studies that actually end up providing weak support for homeopathy rather than refuting it. I understand why that is (they're meta-studies based on primary studies that were attempting to prove homeopathy was effective) but there are good primary studies, if you dig deep enough. They're old and not all of them are online, though. I'm trying to locate them now, but help would be appreciated. --Pyrrhoneia (talk) 06:52, 13 June 2014 (UTC)

For your enjoyment

http://www.change.org/en-IN/petitions/wikipedia-call-to-action-to-update-homeopathy-at-wikipedia Be aware of online petitions! As a fun sidenote, this clearly demonstrate how homeopaths think how science works: By petition.^^Rka001 (talk) 11:36, 14 June 2014 (UTC)

Why are they calling for "a large number of people sign this petition"? Surely, the less people that sign it, the more effective it will be. ;) AndyTheGrump (talk) 14:46, 14 June 2014 (UTC)
I got a request to sign a petition from change.org to avoid the Homeopathic section's closure at the Bristol (or was it Glasgow?) Hospital which claimed that a petition for it's closure was signed by 2000 sceptics/critics of Homeopathy, while they have 24,000 signatures to avoid its closure and were looking to make it 25,000 signatures. However, are we at wikipedia going to put such trivia into this article? I hope not!—Khabboos (talk) 14:43, 18 June 2014 (UTC)

Positive studies and clinical trials

STUDIES OF THE ACTIVITY OF HOMEOPATHIC MEDICINES

<tbody> </tbody>
ORIGINAL/TRANSLATED TITLE AUTHOR(S) PUBLICATION ACTIVITY STUDY

Inhibition of lymphoblast transformation test (LTT) in phytohaemagglutinin (PHA) with Phytolacca americana in homeopathic dilution

Colas H.,

Aubin M.,

Picard P.,

Lebecq J.C.

Ann. Homéopat.

Fr., 1975, 6: 1-11.

Inhibitory

Lymphoblast

transformation

Inquiry into the limits of biological effects of chemical compounds in tissue culture. I. Low dose effects of mercure chloride

Mansvelt J.D.,

van Amons E.

Z. Naturtorschung,

       

1975, 30:

643-649.

Inhibitory

Lymphocyte

growth

The effects of Belladonna and Ferrum phosphoricum on the chemoluminescence of human poly-morphonuclear neutrophils

Poitevin B.,

Aubin M.,

Royer J.F.

Ann. Homéop. Fr.,

       

1983, 3: 5-12.

Inhibitory

Radical release

Effect of aconitum and veratrum

on the isolated perfused heart of

the common eel (Anguilla anguilla)

Pennec J.P.,

Aubin M.

Comp. Biochem.

Physiol., 1984,

776: 367-369.

Protective Aconitine toxicity

Elements of homeopathic

pharmacology

Aubin M.

Homéopathie

Franç., 1984, 72:

231- 235

Protective Aconitine toxicity

The effect of homeopathic

preparations on the phagocyte

activity of granulocytes. In vitro

tests and double-blind controlled

trials

Wagner H.,

Jurcic K.,

Doenicke A.,

Rosenhuber E.,

Behrens N.

Arzneim.

Forsch./Drug Res.,

       

1986, 36:

1424-1425.

Stimulant Phagocytosis

Approach to quantitative analysis

of the effect of Apis mellifica on

the degranulation of human

basophils cultivated in vitro

Poitevin B.,

Aubin M.,

Benveniste J.

Innov. Tech. Biol.

Med., 1986, 7:

64-68.

Inhibitory

Basophil

degranulation

In vitro stimulation of human granulocytes and lymphocytes by pico- and femtogram quantities of cytostatic agents

Wagner H.,

Kreher B.,

Jurcic K.

Arzneim. Forsch./Drug Res., 1988, 38: 273-275.

Stimulant

Lymphocyte

growth

In vitro immunological

degranulation of human basophils

is modulated by lung histamine

and Apis mellifica

Poitevin B.,

Davenas E.,

Benveniste J.

Brit. J. Clin.

Pharmacol., 1988,

25: 439-444.

Inhibitory

Basophil

degranulation

Cytotoxic agents as

immunomodulators

Wagner H.,

Kreher B.

Proc. of the 3rd

GIRI meeting,

Paris, 1989, 31-

46.

Stimulant

Lymphocyte

growth

Contributions of fundamental

research in homeopathy

Boiron J.,

Belon P.

Berl. J. Res. Hom.,

       

1990, 1: 34-35.

Inhibitory

Basophil

degranulation

Synergism of action between

indoleacetic acid (IAA) and highly

diluted solutions of CaCO3 on the

growth of oat coleoptiles

Bornoroni C.

Berl. J. Res. Hom.,

       

1991, 1 (4/5):

275-278.

Stimulant

Growth of plant

cells

Study of the action of

Hahnemannian dilutions of

mercury chloride on the mitotic

index in animal cell cultures.

Boiron J.,

Abecassis J.,

Cotte J.,

Bernard A.M.

Ann. Homéop.

Fr., 1991, 23:

43-49.

Protective Hg toxicity

Dual effects of formylpeptides on

the adhesion of endotoxin-primed

human neutrophils

Bellavite P.,

Chirumbolo S.,

Lippi G.,

Andrioli G.,

Bonazzi L.,

Ferro I.

Cell. Biochem.

Funct., 1993, 11:

231-239.

Inhibitory

Cell adhesion

(bact. pept.

10-8-10-9)

Effects of homeopathic

preparations of organic acids and

of minerals on the oxidative

metabolism of human neutrophils

Chirumbolo S.,

Signorini A.,

Bianchi I.,

Lippi G.,

Bellavite P.

Br. Hom. J., 1993,

82: 227-244.

Inhibitory

Leucocyte

activation

(metabolism)

Platelets/endothelial cells

interactions in presence of

acetylsalicylic acid at ultra low

dose

Doutremepuich

C.,

Lalanne M.C.,

Ramboer I.,

Sertillanges

M.N.,

De Seze O.

Omeomed 92 (C.

Bornoroni, ed.),

       

1993, Editrice

Compositori,

Bologna:

109-115.

Inhibitory

Prostacyclin

release

Effect of high dilutions of epidermal

growth factor (EGF) on in vitro

       

proliferation of keratinocyte and

fibroblast cell lines

Fougeray S.,

Moubry K.,

Vallot N.,

Bastide M.

Br. Hom. J., 1993,

82: 124-125.

Inhibitory

Growth of

keratinocytes

Effects of different homeopathic

potencies of Lachesis on

lymphocyte cultures obtained

from rabbit blood

Enbergs H.,

Arndt G.

Biol. Tier., 1993,

4.

Stimulant

Mitotic and

immunostimulating

activity (bact. pept

10-5-10-6)

The effect of homeopathic

potencies of housedust mite on

the migration of house-dust sensitive

human leukocytes

Gibson S.L.,

Gibson R.G.

Complement.

Ther. Med., 1996,

4: 169-171.

Stimulant

Leucocyte

chemotaxis

The effects of Nux vomica

Homaccord and Atropinum comp.

on intestinal activity in vitro

Kanui T.I.,

Enbergs H.

Biol. Tier., 1996/1,

43-47.

Stimulant

Contraction of

intestinal muscles

Application of flow cytometry to

the analysis of the

immunosuppressive effect of

histamine dilutions on human

basophil action: effect of

cimetidine

Sainte-Laudy J.,

Belon P.

Inflamm. Res.,

       

1997, 46:

S27-S28.

Inhibitory

Basophil

degranulation

Effects of Podophillum pellatum

compounds in various

preparations and dilutions on

human neutrophil functions in

vitro

Chirumbolo S.,

Conforti A.,

Lussignoli S.,

Metelmann H.

et Al.

Br. Hom. J., 1997;

86-16.

Inhibitory

Release of

superoxides

In vivo and in vitro studies on the

efficiency of potentized and nonpotentized

substances

Harisch G.,

Dittmann J.

BT, 1997, 2;

40-46.

Difference between

potentised and

non-potentised

substances

In vivo and in

vitro study; basic

research

Experiments with the effects of

Ubichinon-Injeel and strong

Ubichinon-Injeel on an acellular

system

Harisch G.,

Dittmann J.

BM, 1997, 3;

99-104.

Different effects of

associations of

various potencies and

individual potencies

In vitro study;

basic research

Efficacy of the homeopathic drugs

Suis and Arnica comp.-Heel® on

lymphocyte and phagocyte

activity

Enbergs H.

BM, 1998, 1;

3-11.

Effect of

organotherapeutics

and Arnica comp. -

Heel® on immune

system cells

In vitro study;

basic research

Influence of dilutions and

potencies of cAMP on different

enzymatic systems

Harisch G.,

Dittmann J.

BM, 1998, 2;

55-62.

Effects of dilutions

and potencies of

cAMP on some

enzymatic activities

In vitro study;

basic research

Studies of the principles of

homeopathy; the changeover

from in vivo to in vitro

       

experimental research

Harisch G.,

Dittmann J.

BM, 1998, 3;

98-103.

Potentised and

non-potentised

dilutions are

equally effective,

but have different

actions

Basic research

Determination of the activity of acid phosphatase with cAMP at various potencies

Harisch G.,

Dittmann J.

BM, 1999, 1; 4-8.

Different effects on enzymatic activity

In vitro study;

basic research

Contribution to study of the

efficacy of homeopathic potencies

of phosphorus

Gomez J.C.

BT, 1999, 2;

53-57.

Effect of different

potencies of

phosphorus

Tests on guinea

pigs

Determination of the activity of

acid phosphatase in the presence

of Ubichinon comp.

Harisch G.,

Dittmann J.

BM, 1999, 4;

188-194.

Effect of enzymatic

activity of

homeopathic

medicine

Basic research

Biochemical efficacy of

homeopathic and electronic

preparations of D8 potassium

cyanate

Dittmann J.,

Kanapin H.,

Harisch G.

FKM, 1999, 6;

15-18.

Homeopathic

potentisation is

more effective than

electronic

potentisation

Basic research

Osteoporosis in vitro in rat tibiaderived

osteoblasts is promoted

by the homeopathic preparation,

FMS Calciumfluor

Palermo C.,

Filanti C.,

Poggi S.,

Manduca P.

Cell Biol Int, 1999,

23(1): 31-40.

Stimulant

Osteogenesis

(trial with

compound drug)

Thin-layer chromatography (TLC)

of homeopathic active

constituents

Schmolz M.

BM, 1999, 5;

248-250.

Constituents of Arnica comp.- Heel® ointment: electrophoresis accelerates their skin penetration.

Basic research
Effect of homeopathic
       constituents on enzymatic
activity.
Basic research

Efficacy of a potentised

homeopathic drug in reducing

cytotoxic effects produced by

arsenic trioxide in mice

Datta S.,

Mallick P.,

Bukhsh A.R.

Complement Ther

Med, 1999 Jan;

7 (8): 62-75 (a).

Protective

Arsenic trioxide

toxicity

Efficacy of a potentised

homeopathic drug in reducing

cytotoxic effects produced by

arsenic trioxide in mice

Datta S.,

Mallick P.,

Bukhsh A.R.

Complement Ther

Med, 1999 Sep;

7 (3): 156-63 (b).

Protective

Arsenic trioxide

toxicity

Non-cytotoxic antiviral action of a homeopathic drug

Heine H.

Ärzteitschrift für

Neturheilverfahre,

       

2000; 41: 542-7.

Stimulant

γ interferon

synthesis

Efficacy of a potentised

homeopathic drug in reducing

cytotoxic effects produced by

arsenic trioxide in mice

Kundu S.N.,

Mitra K.,

Khuda

Bukhsh A.R.

Complement Ther

Med , 2000 Sep;

1 (3): 157-65.

Protective

Arsenic trioxide

toxicity

Stimulatory effect of some plant

extracts used in homeopathy on

the phagocytosis induced

chemiluminescence of

polymorphonuclear leukocytes

Crocnan D.,

Greabu M.,

Olinescu R.

Rocz Akad Med

Biochemist, 2000;

45: 246-254.

Stimulant

Phagocytosis

Difference between the efficacy

of single potencies and chords

Dittmann J.,

Harisch G.

BM, 2000, 1;

18-23.

Potency chords are

more effective than

single potencies

Basic research

Influence of some homeopathic

drugs on the catalytic activity of

uricase, acid phosphatase and the

cytosol glutathion-S-transferase

Dittmann J.,

Kanapin H.,

Harisch G.

BM, 2000, 3;

125-131

Effect of D8

potencies on three

different enzymatic

systems

Basic research

Influence of some homeopathic

drugs on the catalytic activity of

cAMP-dependent protein kinases

Dittmann J.,

Kanapin H.,

Harisch G.

BM, 2000, 6;

289-296.

Effect of different

potencies of 5

substances on

enzymatic activity

Basic research

Neuroprotection from glutamate

toxicity with ultra-low dose

glutamate

Jonas W.,

Lin Y.,

Zortella F.

Neuroreport,

       

2001 Feb 92; 12

(2): 335-9.

Protective Glutamate toxicity

 

KEY: BT = Biomedical Therapy

BM = Biologische Medizin

FKM = Forschung Komplementär Medizin

Categories: